跳至主要内容
临床试验/ISRCTN24929928
ISRCTN24929928已完成不适用

A neuroscience perspective on anxiety proneness - sex differences, monoaminergic pathways and treatment response: a randomised controlled trial

ppsala University (Sweden)0 个研究点目标入组 96 人开始时间: 2011年8月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Social anxiety disorder (social phobia), according to DSM-IV, must be the main diagnosis as assessed with the structured clinical interview for DSM disorders (SCID)
  • 2. Otherwise somatically healthy
  • 3. Age 18 or older but not postmenopausal
  • 4. Willingness to participate in a symptom provocation brain imaging trial
  • Healthy controls:
  • 1. No psychiatric diagnosis and otherwise somatically healthy
  • 2. Age 18 or older but not postmenopausal
  • 3. Willingness to participate in a brain imaging trial

排除标准

  • 1. Treatment of social anxiety within the three months preceding the study
  • 2. Current serious or dominant psychiatric disorder other than social anxiety disorder (e.g. psychosis, major depressive disorder, bipolar disorder)
  • 3. Suicidal ideation
  • 4. Chronic use of prescribed medication that could influence the results
  • 5. Abuse of alcohol or narcotics
  • 6. Pregnancy or planned pregnancy during the study period
  • 7. Menopause
  • 8. Previous positron emission tomography (PET) examination
  • 9. Contraindications for MRI investigations (e.g. implants or other metal objects in the body, brain and heart operations)

研究者

发起方
ppsala University (Sweden)

相似试验

A neuroscience perspective on anxiety proneness -... | 临床试验